From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Past Events

Real-World Data Webinar Series: Assessing Registries to Support Regulatory Decision-Making for Drug and Biological Products
The fifth annual Innovations in Regulatory Science Awards presented by the Reagan-Udall Foundation for the FDA will be held Tuesday, December 14, 2021
  Real-World Data Webinar Series:
A Public Webinar
A virtual public workshop to discuss a practical research agenda toward treatment development for stimulant use disorder. 
COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics  
- FDA and the Reagan-Udall Foundation for the FDA held a virtual public meeting on the potential medication error risks with investigational drug container labels. We solicited input from stakeholders (e.g., sponsors, investigators, clinical sites, entities that supply or label investigational drugs, and study participants) on the risk of medication errors related to the content and format of information on investigational drug container labels, the prevalence and nature of medication errors, and practices that might minimize the potential for such errors.
Each year, the Reagan-Udall Foundation for the FDA conducts an Annual Public Meeting of its Board of Directors to share its activities in support of the U.S. Food and Drug Administration. This free virtual meeting is open to the public, but advanced registration is required.
Join leaders in the regulatory field on December 11, 2019, to honor leaders and innovators making a significant impact on America's public health.